【24h】

The role of nitric oxide in amyotrophic lateral sclerosis

机译:一氧化氮在肌萎缩性侧索硬化中的作用

获取原文
获取原文并翻译 | 示例
       

摘要

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by selective motor neuronal death. The cause of ALS is unclear, but accumulating evidence, such as the insufficient clearance of glutamate through the glutamate transporter, and the specific distribution of Ca~(2+)-permeable AMPA receptors in spinal motor neurons, indicates that glutamate-induced neurotoxicity is involved in its pathogenesis. Interestingly, nitric oxide (NO), which has been identified as an endothelium-derived relaxing factor (EDRF), was found to be a pivotal inducer of glutamate-induced neuronal death. NO is generated by nitric oxide synthase (NOS), of which there are three subtypes: neuronal NOS expressed mainly in neurons, inducible NOS in astroglia, and endothelial NOS in vessels. No-related toxicity is caused by peroxynitrite, formed by the reaction of NO with superoxide anions, resulting in the nitration of tyrosine residues in neurofilaments, irreversible inhibition of the mitochondrial respiratory chain, and inhibition of the glutamate transporter. Clinically, the axonal spheroids of motor neurons are reported to be immunoreactive to anti-nitrotyrosine antibody, and there are elevated levels of the metabo-lites of NO in the cerebrospinal fluid of ALS patients. Since physiologically normal motor neurons express limited amounts of neuronal NOS, the source of NO is considered to be non-motor neurons expressing neuronal NOS, astroglia expressing inducible NOS, or motor neurons themselves inducing neuronal NOS. Conversely, neurons containing neuronal NOS are known to be resistant to toxic stimuli, which raises the possibility that such neurons are protected by NO. Several mechanisms have been reported to mediate the NO-related neuroprotection, including cyclic guanosine 3',5'-monophosphate (cyclic GMP), a downstream product of NO generation. This review summarizes previous studies on NO, focusing on its dual functions of neurotoxicity or neuroprotection, and discusses the putative roles of NO in relation to the pathogenesis of ALS.
机译:肌萎缩性侧索硬化症(ALS)是一种致命的神经退行性疾病,其特征在于选择性运动神经元死亡。 ALS的病因尚不清楚,但有越来越多的证据,例如通过谷氨酸转运蛋白清除谷氨酸的能力不足,以及脊髓运动神经元中Ca〜(2+)渗透性AMPA受体的特定分布,表明谷氨酸诱导的神经毒性是参与其发病机理。有趣的是,一氧化氮(NO)已被确定为内皮源性舒张因子(EDRF),被发现是谷氨酸诱导神经元死亡的关键诱因。 NO是由一氧化氮合酶(NOS)产生的,NOS有三种亚型:主要在神经元中表达的神经元NOS,在星形胶质细胞中可诱导的NOS和在血管中的内皮NOS。 NO与超氧阴离子的反应形成的过氧亚硝酸盐不会引起相关毒性,导致神经丝中酪氨酸残基的硝化,线粒体呼吸链的不可逆抑制和谷氨酸转运蛋白的抑制。临床上,据报道运动神经元的轴突球体对抗硝基酪氨酸抗体具有免疫反应性,并且ALS患者的脑脊液中NO的代谢产物水平升高。由于生理上正常的运动神经元表达的神经元NOS数量有限,因此NO的来源被认为是表达神经元NOS的非运动神经元,表达可诱导NOS的星形胶质细胞或运动神经元本身诱导的神经元NOS。相反,已知含有神经元NOS的神经元对毒性刺激具有抗性,这增加了这种神经元被NO保护的可能性。据报道,有几种机制可介导NO相关的神经保护作用,包括环状鸟苷3',5'-单磷酸(环状GMP),NO生成的下游产物。这篇综述总结了以前关于NO的研究,重点是其神经毒性或神经保护的双重功能,并讨论了NO与ALS发病机理有关的推定作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号